Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Pharmacy staff profile

Dr Shyamal Das

PositionSenior Lecturer
QualificationsMPharm PhD
Research summaryDrug formulation and delivery
Teaching
  • PHCY211: Fundamental Pharmaceutical Sciences
  • PHCY220: Integrated modules A
  • PHCY310: Integrated modules B
  • PHCY430: Elective Projects B
  • PHCY480: Honours Research Project (Course Co-ordinator)
  • PHCY485: Applied Pharmacotherapy and Patient Care for Honours (Course Co-ordinator)
  • Inter Professional Education
  • Programme Co-ordinator for BPharm(Hons) programme
Memberships
  • The Aerosol Society (2013 to present)
  • Australasian Pharmaceutical Science Association (APSA) (2006 to present)
  • Otago Medical School Research Society: Treasurer (2019 to present), Executive Committee Member (2018)
  • New Zealand Chapter of the Controlled Release Society (2013 to present): Treasurer (May 2019 to present), Executive Committee Member (Oct 2017 to Apr 2019)
  • Otago Global Health Institute: Profiled Network Member (2016 to present)

Research

My research interests revolve around drug delivery, in particular, respiratory drug delivery of powder formulations for treating chronic lung conditions such as COPD, asthma, tuberculosis, lung cancer and lung infections.

My aim is to achieve a fundamental knowledge base on solid state characterisation processes to understand various pharmaceutical processes such as milling, mixing, spray drying, amorphisation, micronisation, crystallisation, relaxation, dissolution, coating and storage. These knowledge and innovating approaches can be used to develop various conventional and controlled release solid dosage forms such as powders for respiratory delivery as well as tablets and capsules for oral delivery.

Dr Das has extensive research networks with collaborators in New Zealand, Australia, Europe, Asia, the United Kingdom and the USA.

PhD projects available

Please contact me if you are interested in conducting PhD research in the following areas:

  • Interactions and influence of lung surfactant on dissolution in the lung
  • Solid surface characteristics that influence powder delivery to the lung

Additional details

Previous positions

  • Research Fellow, Monash Institute of Pharmaceutical Sciences, Monash University, Australia (2008–2013)
  • Teaching Assistant, Department of Pharmaceutics and Department of Pharmacy Practice, Monash University, Australia (2005–2008)
  • Assistant Professor, Department of Pharmacy, Jahangirnagar University, Bangladesh (2003–2004)
  • Lecturer, Department of Pharmacy, Jahangirnagar University, Bangladesh (2000–2003)

Teaching and research awards

  • Winner of the Otago University Students’ Association’s 2017 Teaching Excellence Award: Premier Lecturer Award 2017 Division of Health Sciences
  • Winner of the Otago University Students’ Association’s Supervisor of the Year Award 2017 Division of Health Sciences
  • Winner of the School of Pharmacy’s Excellence in Teaching Award 2016
  • Winner of the Otago University Students’ Association’s 2016 Teaching Excellence Award (Top Five Teacher)
  • Winner of the Otago School of Pharmacy’s Emerging Researcher Award 2016
  • Finalist (top five) for the Australasian Pharmaceutical Scientists Association’s 2016 Early Career Investigator Award
  • Health Research Council of New Zealand’s Emerging Researcher First Grant 2015

School of Pharmacy administrative roles

  • Chair, BPharm(Hons) Committee (since 2014)
  • Member, Research and Postgraduate Committee (since March 2019)
  • Member, School of Pharmacy Research Committee (since February 2017)
  • Member, School of Pharmacy Undergraduate Programmes Committee
  • Member, School of Pharmacy BPharm/BPharm(Hons) Curriculum Committee (since November 2017)
  • Self-Review Coordinator of BPharm(Hons) Programme (2018)
  • Member, School of Pharmacy Admission Working Party (June 2016 to June 2018)

Publications

Eedara, B. B., Tucker, I. G., & Das, S. C. (2016). Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis. International Journal of Pharmaceutics, 506(1-2), 174-183. doi: 10.1016/j.ijpharm.2016.04.038

Momin, M. A. M., Tucker, I. G., Doyle, C. S., Denman, J. A., & Das, S. C. (2018). Manipulation of spray-drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug. International Journal of Pharmaceutics, 543, 318-327. doi: 10.1016/j.ijpharm.2018.04.003

Eedara, B. B., Rangnekar, B., Doyle, C., Cavallaro, A., & Das, S. C. (2018). The influence of surface active L-leucine and 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) in the improvement of aerosolization of pyrazinamide and moxifloxacin co-spray dried powders. International Journal of Pharmaceutics, 542(1-2), 72-81. doi: 10.1016/j.ijpharm.2018.03.005

Momin, M. A. M., Tucker, I. G., Doyle, C. S., Denman, J. A., Sinha, S., & Das, S. C. (2018). Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections. International Journal of Pharmaceutics, 541(1-2), 26-36. doi: 10.1016/j.ijpharm.2018.02.026

Khadka, P., Dummer, J., Hill, P. C., & Das, S. C. (2018). Considerations in preparing for clinical studies of inhaled rifampicin to enhance tuberculosis treatment. International Journal of Pharmaceutics, 548(1), 244-254. doi: 10.1016/j.ijpharm.2018.07.011

Journal - Research Article

Momin, M. A. M., Tucker, I. G., Doyle, C. S., Denman, J. A., Sinha, S., & Das, S. C. (2018). Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections. International Journal of Pharmaceutics, 541(1-2), 26-36. doi: 10.1016/j.ijpharm.2018.02.026

Khadka, P., Dummer, J., Hill, P. C., & Das, S. C. (2018). Considerations in preparing for clinical studies of inhaled rifampicin to enhance tuberculosis treatment. International Journal of Pharmaceutics, 548(1), 244-254. doi: 10.1016/j.ijpharm.2018.07.011

Eedara, B. B., Rangnekar, B., Doyle, C., Cavallaro, A., & Das, S. C. (2018). The influence of surface active L-leucine and 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) in the improvement of aerosolization of pyrazinamide and moxifloxacin co-spray dried powders. International Journal of Pharmaceutics, 542(1-2), 72-81. doi: 10.1016/j.ijpharm.2018.03.005

Momin, M. A. M., Tucker, I. G., Doyle, C. S., Denman, J. A., & Das, S. C. (2018). Manipulation of spray-drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug. International Journal of Pharmaceutics, 543, 318-327. doi: 10.1016/j.ijpharm.2018.04.003

Eedara, B. B., Tucker, I. G., & Das, S. C. (2016). Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis. International Journal of Pharmaceutics, 506(1-2), 174-183. doi: 10.1016/j.ijpharm.2016.04.038

Das, S. C., & Stewart, P. J. (2016). The influence of lung surfactant liquid crystalline nanostructures on respiratory drug delivery. International Journal of Pharmaceutics, 514(2), 465-474. doi: 10.1016/j.ijpharm.2016.06.029

More publications...